Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jason R Krawic"'
Autor:
Mark M Davis, Saghar Kaabinejadian, Abdul Rafeh Naqash, Ashley R Hoover, Jason R Krawic, Xiao-Hong Sun, Qian Yin, Xinbo Yang, K Christopher Garcia, William H Hildebrand, Wei R Chen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 10 (2022)
Background Localized ablative immunotherapies hold great promise in stimulating antitumor immunity to treat metastatic and poorly immunogenic tumors. Tumor ablation is well known to release tumor antigens and danger-associated molecular patterns to s
Externí odkaz:
https://doaj.org/article/44c570bb44974b23b40d2026f5a199d7
Autor:
Corinna A. Kulicke, Gwendolyn M. Swarbrick, Nicole A. Ladd, Meghan Cansler, Megan Null, Aneta Worley, Chance Lemon, Tania Ahmed, Joshua Bennett, Taylor N. Lust, Chelsea M. Heisler, Megan E. Huber, Jason R. Krawic, Laurisa M. Ankley, Savannah K. McBride, Fikadu G. Tafesse, Andrew J. Olive, William H. Hildebrand, Deborah A. Lewinsohn, Erin J. Adams, David M. Lewinsohn, Melanie J. Harriff
Publikováno v:
Communications Biology, Vol 7, Iss 1, Pp 1-13 (2024)
Abstract MR1-restricted T cells have been implicated in microbial infections, sterile inflammation, wound healing and cancer. Similar to other antigen presentation molecules, evidence supports multiple, complementary MR1 antigen presentation pathways
Externí odkaz:
https://doaj.org/article/a188a5d473ac493d8d7f9aa7fe4c7e44
Autor:
Ashley R Hoover, Saghar Kaabinejadian, Jason R Krawic, Xiao-Hong Sun, Abdul Rafeh Naqash, Qian Yin, Xinbo Yang, K Christopher Garcia, Mark M Davis, William H Hildebrand, Wei R Chen
Publikováno v:
Journal for immunotherapy of cancer. 10(10)
BackgroundLocalized ablative immunotherapies hold great promise in stimulating antitumor immunity to treat metastatic and poorly immunogenic tumors. Tumor ablation is well known to release tumor antigens and danger-associated molecular patterns to st
Autor:
Ashley R. Hoover, Kaili Liu, Christa I. DeVette, Jason R. Krawic, Alexandra D. Medcalf, Connor L. West, Tomas Hode, Samuel S.K. Lam, Alana L. Welm, Xiao‐Hong Sun, William H. Hildebrand, Wei R. Chen
Publikováno v:
Clinical and translational medicine. 12(7)
Metastatic breast cancer poses great challenge in cancer treatment. N-dihydrogalactochitosan (GC) is a novel immunoadjuvant that stimulates systemic immune responses when administered intratumourally following local tumour ablation. A combination of
Autor:
Kaili Liu, Ashley R. Hoover, Jason R. Krawic, Christa I. DeVette, Xiao-Hong Sun, William H. Hildebrand, Mark L. Lang, Robert C. Axtell, Wei R. Chen
Publikováno v:
Theranostics
Rationale: B cells have emerged as key regulators in protective cancer immunity. However, the activation pathways induced in B cells during effective immunotherapy are not well understood. Methods: We used a novel localized ablative immunotherapy (LA
Autor:
Xiao Hong Sun, Jason R. Krawic, Delaney Medcalf, Christa I. DeVette, Kaili Liu, Alana L. Welm, Wei R. Chen, William H. Hildebrand, Ashley R. Hoover, Connor L. West
Laser immunotherapy (LIT) combines local photothermal therapy (PTT), to disrupt tumor homeostasis and release tumor antigens, and an intratumorally administered immunostimulant, N-dihydrogalactochitosan (GC), to induce antitumor immune responses. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95ce6c27fe2948ea3f4655ab8ce89ebe
https://doi.org/10.1101/2020.10.02.323006
https://doi.org/10.1101/2020.10.02.323006